Skip to content
2000
Volume 20, Issue 4
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Introduction

This case study presents a rare and fatal instance of Toxic Epidermal Necrolysis (TEN) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome in a 51-year-old male patient diagnosed with Rheumatoid Arthritis (RA).

Case Presentation

The patient was initially treated with sulfasalazine, leflunomide, and hydroxychloroquine, following which he developed a rash, fever, and loose stools. Drug allergy was suspected, and the anti-rheumatic medications were withdrawn, following which, the patient improved. A subsequent attempt was made to treat the RA with methotrexate, prednisolone, and hydroxychloroquine, following which the rash returned along with an increase in severity, including detachment of the epidermis and mucosa, and systemic involvement, both hepatic and renal. The patient ultimately succumbed to multiple organ dysfunction syndrome and neutropenic sepsis.

Conclusion

This case highlights the possibility of DRESS syndrome and Stevens-Johnson Syndrome (SJS)/TEN following treatment with anti-rheumatic medications. Evidence of this is rare, with the exception of sulfasalazine. This case also considers that the signs of a moderately severe adverse drug reaction could be the early warning signs of DRESS syndrome, which can be difficult to manage and may turn fatal. Additionally, this case highlights the need for maintenance of quality health records in low- and middle-income countries due to the failure to identify hydroxychloroquine as a suspected drug inducing the initial adverse reaction that resulted in it being prescribed again, leading to a fatal outcome.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cds/10.2174/0115748863337976241215162908
2025-01-13
2025-10-11

  • From This Site

    /content/journals/cds/10.2174/0115748863337976241215162908
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. TemparkT. JohnS. RerknimitrP. SatapornpongP. SukasemC. Drug-induced severe cutaneous adverse reactions: Insights into clinical presentation, immunopathogenesis, diagnostic methods, treatment, and pharmacogenomics.Front. Pharmacol.20221383204810.3389/fphar.2022.832048 35517811
     [Google Scholar]
  2. The RegiSCAR ProjectAvailable from: http://www.regiscar.org/Project.html
  3. ChoY.T. YangC.W. ChuC.Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): An interplay among drugs, viruses, and immune system.Int. J. Mol. Sci.2017186124310.3390/ijms18061243 28598363
     [Google Scholar]
  4. SchunkertE.M. DivitoS.J. Updates and insights in the diagnosis and management of DRESS syndrome.Curr. Dermatol. Rep.202110419220410.1007/s13671‑021‑00348‑z 34777921
     [Google Scholar]
  5. WangL. VargheseS. BassirF. Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.Front. Med.2022994952010.3389/fmed.2022.949520 36091694
     [Google Scholar]
  6. RaoS. SunkaraA. SrivastavaN. SampatP. RamosC. AlbertE. An uncommon presentation of dress syndrome secondary to leflunomide use: A case report.J. Investig. Med. High Impact Case Rep.20219232470962199728210.1177/2324709621997282 33629602
     [Google Scholar]
  7. VaishA K TripathiA K GuptaL K JainN AgarwalA VermaS K An unusual case of dress syndrome due to leflunomide.Case Rep20112011bcr062011433010.1136/bcr.06.2011.4330
     [Google Scholar]
  8. Azithromycin/hydroxychloroquine.Reactions Weekly20201819160010.1007/s40278‑020‑82603‑3
     [Google Scholar]
  9. AquinoR.T.R. VergueiroC.S.V. MagliariM.E.R. FreitasT.H.P. Sulfasalazine-induced DRESS syndrome (drug rash with eosinophilia and systemic symptoms).Sao Paulo Med. J.2008126422522610.1590/S1516‑31802008000400006 18853032
     [Google Scholar]
  10. GirelliF. BernardiS. GardelliL. A new case of dress syndrome induced by sulfasalazine and triggered by amoxicillin.Case Rep. Rheumatol.201320131310.1155/2013/409152 23936716
     [Google Scholar]
  11. KanabajK. JenerowiczD. JankowskaL. ŻabaZ. DRESS syndrome – A dermatological emergency – Sulfasalazine-related acute drug reaction case report.Heliyon202399e2002110.1016/j.heliyon.2023.e20021 37809745
     [Google Scholar]
  12. RoyleJG KrishnaG MoorthyA 136 Sulfasalazine induced DRESS syndrome: A rare side effect of a common medication.Rheumatology201958Suppl. 3kez108.04410.1093/rheumatology/kez108.044
     [Google Scholar]
  13. KuchinskayaE.M. ChikovaI.A. KostikM.M. Case report: Sulfasalazine-induced hypersensitivity.Front. Med.202310114033910.3389/fmed.2023.1140339 37293296
     [Google Scholar]
  14. SoriaA. BernierC. VeyracG. BarbaudA. PuymiratE. MilpiedB. Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study.J. Am. Acad. Dermatol.202082360661110.1016/j.jaad.2019.09.036 31562941
     [Google Scholar]
  15. Ben FredjN. AouamK. ChaabaneA. Hypersensitivity to amoxicillin after drug rash with eosinophilia and systemic symptoms (DRESS) to carbamazepine and allopurinol: A possible co‐sensitization.Br. J. Clin. Pharmacol.201070227327610.1111/j.1365‑2125.2010.03685.x 20653681
     [Google Scholar]
  16. SriratanaviriyakulN. NguyenL.P. HendersonM.C. AlbertsonT.E. Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: A case report.J. Med. Case Rep.20148133210.1186/1752‑1947‑8‑332 25297051
     [Google Scholar]
  17. YanY. WuL. LiX. ZhaoL. XuY. Immunomodulatory role of azithromycin: Potential applications to radiation-induced lung injury.Front. Oncol.20231396606010.3389/fonc.2023.966060 36969016
     [Google Scholar]
  18. González-RamosJ. Noguera-MorelL. TongH.Y. Two cases of overlap severe cutaneous adverse reactions to benznidazole treatment for asymptomatic Chagas disease in a nonendemic country.Br. J. Dermatol.2016175360460710.1111/bjd.14451 26851874
     [Google Scholar]
  19. MartínezJ.D. FrancoR. SáenzL.M. DRESS and stevens–johnson syndrome overlap secondary to allopurinol in a 50-year-old man-a diagnostic and treatment challenge: Case report.Life (Basel)20231312225110.3390/life13122251 38137852
     [Google Scholar]
  20. Van NguyenK Van VuQ TranMH Overlapping stevens-johnson syndrome and dress syndrome caused by phenobarbital: A vietnamese case report.Glob Pediatr Health2023>102333794X23121655610.1177/2333794X231216556 38073663
     [Google Scholar]
  21. CasagrandaA. SuppaM. DehavayF. del MarmolV. Overlapping dress and stevens-johnson syndrome: Case report and review of the literature.Case Rep. Dermatol.2017921710.1159/000475802 28611628
     [Google Scholar]
  22. BlackR.J. CrossM. HaileL.M. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021.Lancet Rheumatol.2023510e594e61010.1016/S2665‑9913(23)00211‑4 37795020
     [Google Scholar]
  23. GabrielS.E. The epidemiology of rheumatoid arthritis.Rheum. Dis. Clin. North Am.200127226928110.1016/S0889‑857X(05)70201‑5 11396092
     [Google Scholar]
  24. ShahsavariniaK. GhojazadehM. GhabousianA. HatefniaF. SoleimanpourM. SoleimanpourH. An umbrella review of clinical efficacy and adverse cardiac events associated with hydroxychloroquine or chloroquine with or without azithromycin in patients with COVID-19.Anesth. Pain Med.2021114e11582710.5812/aapm.115827 34692436
     [Google Scholar]
  25. Tahsini TekantapehS. GhojazadehM. GhamariA.A. MohammadiA. SoleimanpourH. Therapeutic and anti-inflammatory effects of baricitinib on mortality, ICU transfer, clinical improvement, and CRS-related laboratory parameters of hospitalized patients with moderate to severe COVID-19 pneumonia: A systematic review and meta-analysis.Expert Rev. Respir. Med.202216101109113210.1080/17476348.2022.2114899 35981253
     [Google Scholar]
  26. NikniazZ. MahdaviR. NikniazL. Assessment of the effect of Elaeagnus angustifolia on anthropometric characteristics and dietary intake in patients with osteoarthritis: A randomized clinical trial.Int J Drug Res Clin20231e2010.34172/ijdrc.2023.e20
     [Google Scholar]
  27. RaduA.F. BungauS.G. Management of rheumatoid arthritis: An overview.Cells20211011285710.3390/cells10112857 34831081
     [Google Scholar]
/content/journals/cds/10.2174/0115748863337976241215162908
Loading
A Rare Case of Fatal Toxic Epidermal Necrolysis (TEN) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome in a Patient with Rheumatoid Arthritis
Curr Drug Saf 20, 532 (2025); https://doi.org/10.2174/0115748863337976241215162908
/content/journals/cds/10.2174/0115748863337976241215162908
/content/journals/cds/10.2174/0115748863337976241215162908
Loading

Data & Media loading...


  • Article Type:     Case Report
Keyword(s): Anti-rheumatic drugs; cutaneous adverse drug reactions; DRESS syndrome; hydroxychloroquine; leflunomide; stevens-johnson syndrome (SJS); sulfasalazine; toxic epidermal necrolysis (TEN)

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test